Ondansetron Dosing for a 6-Year-Old Female
For a 6-year-old child of average weight (approximately 20 kg), administer ondansetron 0.15 mg/kg intravenously (3 mg) or 4 mg orally, with doses repeated every 8 hours as needed for nausea and vomiting. 1, 2
Weight-Based Dosing Calculation
- Average weight for a 6-year-old female: approximately 20 kg
- Standard pediatric IV dosing: 0.15 mg/kg per dose 3, 4
- For a 20 kg child: 0.15 mg/kg × 20 kg = 3 mg IV per dose
- Standard pediatric oral dosing: 4 mg orally per dose 5, 3
- Dosing interval: Every 8 hours as needed 1, 2
Context-Specific Dosing Recommendations
For Chemotherapy-Induced Nausea/Vomiting
- Moderate emetogenic chemotherapy: 0.15 mg/kg IV (3 mg for 20 kg child) given 30 minutes before chemotherapy, then every 8 hours for 1-2 days post-treatment 6, 3
- Highly emetogenic chemotherapy: Same IV dosing, but should be combined with dexamethasone for enhanced efficacy 6, 3
- Alternative oral dosing: 4 mg orally every 8 hours, starting before chemotherapy 3
For Acute Gastroenteritis
- Oral dosing preferred: 4 mg orally as a single dose, with option to repeat every 8 hours 5
- In the landmark gastroenteritis trial, children aged 6 months to 12 years received oral ondansetron with significant reduction in vomiting episodes and IV fluid requirements 5
For Postoperative Nausea/Vomiting
- Single prophylactic dose: 0.1-0.15 mg/kg IV (2-3 mg for 20 kg child) given before or at the end of surgery 3
- This dosing has proven superior to placebo, droperidol, and metoclopramide in pediatric surgical patients 3
Important Clinical Considerations
Maximum Dosing Limits
- Maximum single IV dose: Do not exceed 16 mg per dose in any patient due to cardiac safety concerns 2
- Maximum daily dose: Should not exceed 32 mg total per 24 hours 1
- For this 6-year-old, the calculated 3 mg IV dose is well below safety thresholds 3
Formulation Options
- Oral dissolving tablets (ODT): Available in 4 mg strength, ideal for children who have difficulty swallowing 6, 1
- Oral solution: Can be compounded if needed 3
- IV formulation: 0.15 mg/kg (3 mg for 20 kg child) administered over 2-5 minutes 3, 4
Management of Breakthrough Nausea
- If nausea persists despite ondansetron: Add (do not replace) a medication with a different mechanism of action 1
- Avoid simply re-dosing ondansetron too soon: The half-life is 3.5 hours, so therapeutic levels persist for several hours after administration 4, 7
Common Pitfalls and Caveats
Adverse Effects to Monitor
- Headache: Most common adverse effect in pediatric patients 3, 7
- Constipation: Can occur and may paradoxically worsen nausea if severe 1
- Increased diarrhea: Noted specifically in gastroenteritis patients receiving ondansetron 5
- Sedation and drowsiness: Generally mild but should be monitored 3, 4
When Ondansetron May Be Insufficient
- For highly emetogenic chemotherapy: Ondansetron monotherapy is inadequate; must combine with dexamethasone and consider NK1 receptor antagonists 6, 2
- For delayed nausea: Efficacy beyond 24-48 hours is less well-established; consider adding scheduled dopamine antagonists 1, 4
Dosing Adjustments
- Pediatric patients have increased clearance compared to adults, supporting the higher weight-based dosing (0.15 mg/kg vs. fixed adult doses) 4, 7
- No renal dose adjustment needed: Less than 10% is excreted unchanged in urine 4, 7
- Hepatic metabolism: Use caution in severe liver disease, though specific pediatric guidance is limited 7